104 studies found for:    "Small intestine cancer"
Show Display Options
Rank Status Study
1 Terminated Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Conditions: Non-melanomatous Skin Cancer;   Pancreatic Cancer;   Small Intestine Cancer;   Testicular Germ Cell Tumor
Interventions: Genetic: in situ hybridization;   Genetic: protein expression analysis;   Other: immunologic technique
2 Completed Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer
Conditions: Carcinoma of the Appendix;   Colorectal Cancer;   Small Intestine Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin
3 Recruiting Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
Condition: Small Intestine Cancer
Interventions: Drug: capecitabine;   Drug: irinotecan hydrochloride;   Drug: oxaliplatin
4 Unknown  Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
Condition: Small Intestine Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
5 Active, not recruiting Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer
Conditions: Anal Cancer;   Colorectal Cancer;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Head and Neck Cancer;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Intervention:
6 Withdrawn Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
Conditions: Colorectal Cancer;   Small Intestine Cancer
Intervention: Drug: exisulind
7 Unknown  Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Conditions: Anal Cancer;   Carcinoma of the Appendix;   Colorectal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Liver Cancer;   Nausea and Vomiting;   Pancreatic Cancer;   Primary Peritoneal Cavity Cancer;   Small Intestine Cancer
Interventions: Drug: palonosetron hydrochloride;   Other: placebo
8 Terminated Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
Conditions: Anal Cancer;   Anxiety Disorder;   Breast Cancer;   Depression;   Esophageal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Kidney Cancer;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Interventions: Other: questionnaire administration;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
9 Unknown  Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Conditions: Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: brostallicin;   Drug: doxorubicin hydrochloride
10 Completed Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
Conditions: Colorectal Cancer;   Constipation, Impaction, and Bowel Obstruction;   Extrahepatic Bile Duct Cancer;   Gastric Cancer;   Gastrointestinal Stromal Tumor;   Nausea and Vomiting;   Ovarian Cancer;   Pancreatic Cancer;   Peritoneal Cavity Cancer;   Small Intestine Cancer
Intervention: Drug: octreotide acetate
11 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Genetic: DNA analysis;   Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: 131I-3F8
12 Completed Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Conditions: Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Interventions: Biological: filgrastim;   Drug: docetaxel;   Drug: gemcitabine hydrochloride
13 Completed Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
Conditions: Colorectal Cancer;   Constipation, Impaction, and Bowel Obstruction;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Gastrointestinal Stromal Tumor;   Quality of Life;   Small Intestine Cancer
Interventions: Procedure: bowel obstruction management;   Procedure: quality-of-life assessment
14 Completed Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
Conditions: Colorectal Cancer;   Constipation, Impaction, and Bowel Obstruction;   Extrahepatic Bile Duct Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Gastrointestinal Stromal Tumor;   Pancreatic Cancer;   Quality of Life;   Small Intestine Cancer
Interventions: Procedure: bowel obstruction management;   Procedure: quality-of-life assessment
15 Completed Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
Conditions: Colorectal Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Peritoneal Cavity Cancer;   Small Intestine Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: floxuridine
16 Completed Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
Conditions: Anal Cancer;   Colorectal Cancer;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Liver Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: oxaliplatin
17 Active, not recruiting Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Conditions: Anal Cancer;   Carcinoma of the Appendix;   Colorectal Cancer;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Gastrointestinal Stromal Tumor;   Liver Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Interventions: Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Other: pharmacogenomic studies;   Other: pharmacological study
18 Terminated Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
Conditions: Colorectal Cancer;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Interventions: Biological: carcinoembryonic antigen peptide 1-6D;   Biological: incomplete Freund's adjuvant;   Biological: sargramostim
19 Unknown  Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Liver Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Interventions: Biological: filgrastim;   Biological: recombinant interferon alfa;   Drug: fluorouracil;   Drug: hydroxyurea
20 Active, not recruiting Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Procedure: radionuclide imaging;   Radiation: indium In 111-labeled autologous peripheral blood mononuclear cells;   Radiation: indium In 111-labeled autologous polymorphonuclear leukocytes

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years